News Updates
Application of Stem Cells in Degenerative Orthopedic Diseases
Degenerative orthopedic diseases, traditionally viewed as inevitable “wear-and-tear” processes, are now being reimagined as dynamic failures of tissue homeostasis orchestrated by a complex interplay of chronic inflammation and metabolic exhaustion.
Source: Frontiers
Current Status and Future Prospects of Functionalized Mesenchymal Stem Cells for the Treatment of Spinal Cord Injury
Spinal cord injury (SCI) represents a critical neurological disorder characterized by intricate pathophysiological processes. The hostile local environment induced by secondary damage markedly hinders intrinsic neural repair, and currently available therapies exhibit limited clinical effectiveness. Recently, mesenchymal stem cells (MSCs) have attracted considerable attention due to their paracrine-mediated therapeutic properties, including immunoregulatory effects, neurotrophic factor secretion, and promotion of angiogenesis.
Source: ScienceDirect
Long-Term Safety and Clinical Outcomes from A Single-Site Phase 1 Study of Neural Stem Cell Transplantation for Chronic Cervical Spinal Cord Injury
Neural stem cell transplantation offers a promising avenue for spinal cord injury (SCI) repair, but demonstrating safety and feasibility in human populations remains a critical step. In this phase 1 trial, we investigate the long-term outcomes of cervical spinal cord implantation of NSI-566, a human spinal cord-derived neural stem cell line. With prospective data collection over 60 months, we assess adverse events, functional outcomes, and neurophysiological measures in a small cohort (N = 3) of chronic AIS-A SCI patients.
Source: ScienceDirect
Clinical Application of Mesenchymal Stem Cells in Orthopaedics and Traumatology in Daily Practice
Mesenchymal stem cells (MSCs) have been widely used in preclinical and clinical orthopaedic and traumatology studies (1). Compared to other cell therapies, MSCs have a variety of characteristics, such as a lower risk of teratoma than pluripotent stem cells, stemness potency, targeted therapy through chemo-attraction, ease of isolation, and rapid proliferation (2). However, the application from bench to bedside requires a standardized procedure for its administration (1).
Source: ScienceDirect
Current and Emerging Therapies for Knee Osteoarthritis: From Conventional Approaches to Machine Learning and Stem Cell Innovations
Osteoarthritis is characterized by cartilage degradation and joint distortion. The most prevalent version of osteoarthritis, knee osteoarthritis (KOA), affects millions, acting as a leading cause of disability.
Source: ScienceDirect
Stem Cell-laden 3D Bioprinting for Osteoarthritis: Orchestrating Chondrogenic Induction and Inflammatory Microenvironment Modulation
Osteoarthritis (OA) involves irreversible cartilage degeneration and requires regenerative strategies due to limited self-repair. This review highlights the potential of stem cell-laden 3D bioprinting to engineer biomimetic cartilage scaffolds with precise control. It analyzes bioprinting methods, bioinks, and cell induction strategies, focusing on the synergistic roles of small molecules, growth factors, and exosomes in guiding stem cell differentiation.
Source: ScienceDirect
Expert Opinion on Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell (BMMSC) Therapy for Knee Osteoarthritis: Clinical Insights, Efficacy, and Safety
Knee osteoarthritis (KOA) remains a major cause of disability. Many patients with moderate disease (Kellgren-Lawrence (KL) grade 2-3) continue to experience disease progression, despite receiving guideline-based conservative treatments that primarily offer symptomatic relief. Allogeneic bone marrow-derived mesenchymal stem cells (BMMSCs) have gained attention for their potential anti-inflammatory, immunomodulatory, and chondroprotective effects.
Source: Cureus
